Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." hEPAtic Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02196064

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:51.878886+00:00

Published At

2015-08-05T00:00:00+00:00

Record Updated At

2015-08-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2015-08-05"

protocolSection.identificationModule.nctId

"NCT02196064"

protocolSection.identificationModule.officialTitle

"Hepatic Safety of Eviplera\u00ae in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the \"The HEPAVIR HEPATIC SAFETY Cohort.\" hEPAtic Study."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.